What is the BBIO stock price prediction for next 2 weeks?

According to our price prediction algorithm,BridgeBio Pharma, Inc. (BBIO) price will be around $78.84 in the next 2 weeks. This means it will increase by 3.3242463958060298 from the last closing price. This prediction may vary from other time period filters for BBIO stock.

What can be the highest Possible price of BBIO stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, BBIO can achieve the highest price of $80.50 which is 5.505145414084622 higher than last closing price. This prediction may vary from other time period filters for BBIO stock.

What can be the lowest Possible price of BBIO stock in next 2 weeks?

As per the forecast and algorithmic analysis, BBIO stock price can be as low as $77.38 which is 1.4153148497035155 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for BBIO stock.

Will BBIO stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that BBIO stock will gain3.3242463958060298 in the next 2 weeks. This prediction may vary from other time period filters for BBIO stock.

What is BBIO stock last closing price?

Last closing price of BBIO stock was $76.30.

What is BBIO stock price prediction?

BBIO stock price prediction means predicting the future closing prices of BBIO stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of BBIO stock in a certain time period.

How we predict BBIO stock future prices?

If you are searching for BBIO stock forecast, analysis or price prediction, then you might be wondering what BridgeBio Pharma, Inc. (BBIO) will do in the future. Our BBIO price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This BBIO price prediction will likely answer most of your questions.

How frequent we update BBIO stock predictions?

We are updating the forecasts for the BBIO stock on daily basis.

Is using ML forecasting for BBIO stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for BBIO stock same for all the time periods?

No, the prediction for BBIO stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

BridgeBio Pharma, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$76.302.77%Since 2 Weeks

Predicted Price$78.843.32%For 2 Weeks

Upper Predicted Price$80.505.51%For 2 Weeks

Lower Predicted Price$77.381.42%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of BBIO will rise by +3.32% over the next 2 Weeks and hit $78.84 by Friday, January 2, 2026. In that time frame, BBIO's share price is expected to range between $77.38 and $80.50.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jan 2, 2026	77.19	78.84	80.39
Jan 1, 2026	76.62	78.27	79.78
Dec 31, 2025	76.45	78.04	79.61
Dec 30, 2025	75.72	77.18	78.79
Dec 29, 2025	76.23	77.72	79.23
Dec 26, 2025	76.15	77.57	79.10
Dec 25, 2025	75.50	77.00	78.46
Dec 24, 2025	75.30	76.77	78.24
Dec 23, 2025	74.33	75.91	77.44
Dec 22, 2025	75.01	76.46	78.04

BBIO shares rose +1.39% in Monday, December 22, 2025's trading session, rising from a previous close of $76.30 to move at $77.36. The stock demonstrated notable intraday movement (see BBIO's key stats for a full breakdown), fluctuating between $76.45 and $78.44, a +2.60% trading range. While recent weeks have seen some volatility, BBIO has managed to secure a +5.05% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 4.48M shares changing hands, 3M more than the previous session. This amounted to $346.41M in total market activity.

Will BBIO Continue Its Upward Trend?

According to analyst ratings and projections for BBIO, BridgeBio Pharma, Inc. shares are anticipated to increase by +3.77%, potentially reaching $80.39 per share by January 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for BBIO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the BBIO stock forecast, now is a good time to buy BBIO stock because its current trading price is -1.87% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on BBIO covering social and institutional perspectives.

BBIO Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into BBIO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 67.78% to 69.95%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 65.14%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 62.51%, points to growing bullish momentum over the long term. Insights into BBIO's shareholder base show how institutional investors are positioning themselves during these momentum shifts

BridgeBio Pharma Short-Term Forecasts

BBIO Forecast For Next 5 Days

Our algorithm anticipates BridgeBio Pharma (BBIO) stock could hit $83.07 by Dec 29, 2025. This represents a +7.38% rise from today's price, following a +3.01% change over the past five days.

BBIO Forecast For Next 30 Days

Based on analysis of market trends, the outlook for BridgeBio Pharma, Inc. (BBIO) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $81.71, which would mean a +5.62% increase from the current price of $77.36. Projections for this period range from a high of $84.81 to a low of $73.65.

BBIO Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for BridgeBio Pharma's price over the next three months point to a rise. BBIO stock is expected to peak at $83.02 on Jan 21, 2026 after potentially dipping to $71.69 on Dec 25, 2025. On average, BBIO is likely to trade around $78.65 in the coming 90 days.

BridgeBio Pharma Stock Forecast 2025

Based on our predictive models, BridgeBio Pharma (BBIO) is expected to trade between $71.69 and $79.56 throughout 2025. This would result in an average price of $75.56, potentially offering investors a -2.33% return from current levels.

BridgeBio Pharma, Inc. Monthly Forecast 2025–2026

December 2025

According to our latest forecast models, BridgeBio Pharma, Inc. (BBIO) is positioned to show a strong performance in December 2025. The price is predicted to move between $71.69 and $79.56, settling at an average of $75.56. This could translate to a -2.33% loss.

January 2026

Based on current market signals, BridgeBio Pharma, Inc. is projected to trend january 2026. We forecast a trading range from $74.65 to $83.02, with a likely average price of $79.19. Investors could expect a potential return of +2.37%.

February 2026

Our predictive algorithms indicate BridgeBio Pharma, Inc. stock may see a shift in February 2026. The expected range spans $75.25–$82.66, with an average target of $78.95. This represents a positive outlook and a possible gain of +2.06%.

March 2026

Analyzing established trends, BridgeBio Pharma, Inc. looks set to move in March 2026. Projections place the stock between $75.60 and $82.69, averaging around $79.13. This suggests a +2.29% gain from current levels.

April 2026

Market indicators suggest BridgeBio Pharma, Inc. could experience notable changes during April 2026. Prices could fluctuate within $75.92 to $86.14, with a midpoint forecast of $81.24. The stock might deliver a +5.02% gain.

May 2026

Forecasting for May 2026, models estimate that BridgeBio Pharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $76.84 and $86.20, averaging $81.92. This signals a positive trajectory with potential returns around +5.89%.

June 2026

According to our latest forecast models, BridgeBio Pharma, Inc. (BBIO) is positioned to show a strong performance in June 2026. The price is predicted to move between $80.19 and $88.13, settling at an average of $84.53. This could translate to a +9.27% gain.

July 2026

Based on current market signals, BridgeBio Pharma, Inc. is projected to trend july 2026. We forecast a trading range from $80.32 to $88.51, with a likely average price of $84.37. Investors could expect a potential return of +9.06%.

August 2026

Our predictive algorithms indicate BridgeBio Pharma, Inc. stock may see a shift in August 2026. The expected range spans $80.80–$88.60, with an average target of $84.40. This represents a positive outlook and a possible gain of +9.10%.

September 2026

Analyzing established trends, BridgeBio Pharma, Inc. looks set to move in September 2026. Projections place the stock between $81.96 and $91.84, averaging around $86.83. This suggests a +12.24% gain from current levels.

October 2026

Market indicators suggest BridgeBio Pharma, Inc. could experience notable changes during October 2026. Prices could fluctuate within $82.45 to $92.46, with a midpoint forecast of $87.43. The stock might deliver a +13.02% gain.

November 2026

Forecasting for November 2026, models estimate that BridgeBio Pharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $86.03 and $95.87, averaging $90.08. This signals a positive trajectory with potential returns around +16.44%.

December 2026

According to our latest forecast models, BridgeBio Pharma, Inc. (BBIO) is positioned to show a strong performance in December 2026. The price is predicted to move between $85.80 and $93.28, settling at an average of $89.53. This could translate to a +15.73% gain.

BBIO's history of dividends and stock splits also plays a role in long-term investor confidence.